Stericycle (NASDAQ:SRCL) Coverage Initiated at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Stericycle (NASDAQ:SRCL) in a note issued to investors on Thursday. The firm set a “hold” rating on the business services provider’s stock.

A number of other equities research analysts have also issued reports on SRCL. Robert W. Baird cut their price target on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday, April 26th. Keefe, Bruyette & Woods lifted their price target on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research report on Tuesday, June 4th. Truist Financial lifted their price target on shares of Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research report on Tuesday, June 4th. Stifel Nicolaus lifted their target price on shares of Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a report on Thursday, February 29th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $62.00 target price (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $74.00.

Stericycle Stock Performance

Shares of SRCL stock opened at $58.16 on Thursday. The stock has a market capitalization of $5.40 billion, a P/E ratio of -264.36, a PEG ratio of 3.15 and a beta of 1.08. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. The firm’s 50 day moving average is $50.02 and its 200 day moving average is $50.00. Stericycle has a 12 month low of $37.78 and a 12 month high of $59.45.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.03. The business had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business’s revenue for the quarter was down 2.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.49 EPS. On average, sell-side analysts anticipate that Stericycle will post 2.32 earnings per share for the current year.

Institutional Trading of Stericycle

Institutional investors and hedge funds have recently bought and sold shares of the business. Capital Research Global Investors increased its holdings in Stericycle by 13.4% in the 4th quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock worth $296,762,000 after acquiring an additional 705,586 shares in the last quarter. Sei Investments Co. grew its holdings in shares of Stericycle by 35.5% during the fourth quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock worth $52,601,000 after buying an additional 277,896 shares in the last quarter. Earnest Partners LLC grew its holdings in shares of Stericycle by 12.4% during the first quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock worth $129,766,000 after buying an additional 271,025 shares in the last quarter. Ariel Investments LLC grew its holdings in shares of Stericycle by 5.7% during the third quarter. Ariel Investments LLC now owns 4,328,036 shares of the business services provider’s stock worth $193,506,000 after buying an additional 233,612 shares in the last quarter. Finally, Heartland Advisors Inc. grew its holdings in shares of Stericycle by 55.5% during the fourth quarter. Heartland Advisors Inc. now owns 583,545 shares of the business services provider’s stock worth $29,733,000 after buying an additional 208,256 shares in the last quarter. 98.82% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.